Our office conducts clinical trials with patients who have chronic kidney disease, polycystic kidney disease, glomerular disease, and/or hypertension. Many of our trials assess novel therapies in these populations. This position will serve as the coordinator for an ongoing 12-month interventional trial assessing the effects of a glucagon-like peptide 1 receptor agonist (GLP1) vs. placebo in people with autosomal dominant kidney disease. This position will provide support on other trials in our office as needed.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
1,001-5,000 employees